Work

MTHFD2 is a selective metabolic vulnerability in AML that supports mitochondrial redox homeostasis and venetoclax resistance

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-755

Authors: Judith Sokei, Orsola Di Martino, Mary Basse, Nishanth Gabriel, Conner York, Francesca Ferraro, Stephen Sykes

Institutions: Washington University in St. Louis, University of Parma

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417014153

Cites:

Cited by: 2

Related to: